On the other hand, a recent meta-analysis from 13 studies of 10,016 women with breast cancer [16] concluded that BRCA1 mutation carriers had a worse overall survival but similar progression-free survival, compared to non-carriers; while BRCA2 mutation was not associated with breast cancer prognosis. Here, BRCA1 is linked to breast carcinoma.